Cernostics will evaluate sections from a minimum of one biopsy level from every patient, and can evaluate as many biopsy Read More
About h7LNhJnSDCThis author has not yet filled in any details.
So far h7LNhJnSDC has created 62 blog entries.
The assay requires preparing nine (9) glass slides with serial tissue sections taken at five (5) micron thickness from f Read More
The TissueCypher™ technology is quantitative and objective, which represents a significant improvement over stand Read More
What is the clinical evidence that supports clinical use of the TissueCypher® Barrett's Esophagus Assay?9,10,11
Cernostics has completed two multi-institutional independent clinical validation studies on the TissueCypher™ Bar Read More
The test evaluates multiple epithelial and stromal processes in Barrett’s biopsies to produce an individualized risk sco Read More
The TissueCypher™ Barrett’s Esophagus Assay is offered as a clinical lab service exclusively by Cernostics, a cli Read More
The TissueCypher™ Barrett’s Esophagus Assay is the first test to combine protein expression with tissue structure Read More
Cernostics Announces Scientific Presentations at DDW and ISPOR Meetings Demonstrating Clinical Validation and Cost-Effectiveness of New TissueCypher® Barrett's Esophagus Assay
Test Predicts Development of Esophageal Cancer in Patients with Barrett’s Esophagus
Bethlehem, PA – Cernostics, Inc. Read More
Grant will further validate Cernostics’ diagnostic technology for predicting risk of future progression to Read More
Anatomic pathology (AP) testing, the analysis of tissue through a light microscope by a pathologist is a fundamental too Read More